Universidade Estadual do Centro-Oeste, Laboratory of Pharmaceutical Nanotechnology, Rua Simeão Camargo Varela de Sá 03, 85040-080 Guarapuava, PR, Brazil.
Universidade Estadual do Centro-Oeste, Laboratory of Pharmaceutical Nanotechnology, Rua Simeão Camargo Varela de Sá 03, 85040-080 Guarapuava, PR, Brazil.
Mater Sci Eng C Mater Biol Appl. 2017 Feb 1;71:156-166. doi: 10.1016/j.msec.2016.09.080. Epub 2016 Sep 30.
The purpose of this study was to develop poly(lactic acid) (PLA) nanoparticles containing ursolic acid (UA) by an emulsification-solvent evaporation technique and evaluate the radical scavenging activity over hypochlorous acid (HOCl) and cytotoxicity over erythrocytes and tumor cells. Nanoparticles were successfully obtained and presented mean size of 246nm with spherical or slightly oval morphology, negative zeta potential and 96% of UA encapsulation efficiency. Analyses of FTIR, XRD and DSC-DTG suggest interaction/complexation of UA with PLA matrix and drug amorphization promoted by nanoencapsulation process. Stability study showed that room temperature was the best condition for nanoparticles storage. The in vitro release study showed UA was released from the polymeric matrix over two constants (α, β), suggesting a second order kinetics. After 120h of assay, 60% of UA were released by diffusion. In the HOCl scavenging activity, after 72h of assay UA-loaded nanoparticles presented the same efficacy of free drug. In cytotoxicity test over red blood cells, UA-loaded nanoparticles showed less toxicity on cells than free drug. The cytotoxicity assay over melanoma cells line (B16-F10) showed after 72h that nanoparticles were able to reduce the cell viability in 70%. PLA nanoparticles showed be potential carriers for UA maintaining the antioxidant and antitumor activity of the UA and decreasing its cytotoxicity over normal cells.
本研究旨在通过乳化-溶剂蒸发技术制备载熊果酸(UA)的聚乳酸(PLA)纳米粒,并评价其对次氯酸(HOCl)的清除自由基活性和对红细胞及肿瘤细胞的细胞毒性。成功制备了纳米粒,其平均粒径为 246nm,呈球形或略带椭圆形,具有负 zeta 电位和 96%的 UA 包封效率。FTIR、XRD 和 DSC-DTG 分析表明,UA 与 PLA 基质之间存在相互作用/络合,且药物纳米化促进了药物无定形化。稳定性研究表明,室温是纳米粒储存的最佳条件。体外释放研究表明,UA 从聚合物基质中以两个常数(α、β)释放,提示释放过程符合二级动力学。在 120h 的实验中,通过扩散释放了 60%的 UA。在 HOCl 清除活性研究中,在 72h 的实验中,载 UA 纳米粒与游离药物具有相同的清除效果。在对红细胞的细胞毒性试验中,载 UA 纳米粒的细胞毒性低于游离药物。对黑色素瘤细胞系(B16-F10)的细胞毒性试验显示,在 72h 后,纳米粒能够将细胞活力降低 70%。PLA 纳米粒有望成为 UA 的潜在载体,既能保持 UA 的抗氧化和抗肿瘤活性,又能降低其对正常细胞的细胞毒性。